XVIVO Wins Two Davey Awards: A Gold and a Silver for Two Animation Programs
Biohaven Ltd. (NYSE: BHVN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $59.00 price target on the stock.
Biohaven Ltd. (NYSE: BHVN) had its price target raised by analysts at TD Cowen from $55.00 to $75.00. They now have a "buy" rating on the stock.
Biohaven Ltd. (NYSE: BHVN) had its price target lowered by analysts at Royal Bank of Canada from $68.00 to $66.00. They now have an "outperform" rating on the stock.
Biohaven Non-GAAP EPS of -$1.74 misses by $0.24 Nov. 13, 2024 2:24 AM ET By: Meghavi Singh , SA News Editor [Seeking Alpha]